As shown in Table 2, the foundational role of IL-2 in supporting adoptively transferred TILs was demonstrated in early NSCLC studies, where TILs could be successfully expanded from minimally invasive tumor biopsies (36). The gene discussed is IL2; the disease is non-small cell lung carcinoma.